Major Grants
01
Principal Investigator.
02
£7500. Principal Investigator
03
2022-2023 – Studying longitudinal microbiome shift and antimicrobial resistance (AMR) in association with unrestricted antibiotic usage in a poor Community.; International Strategic Fund (ISF); Awarded value (100%): £4000.
Principal Investigator
04
£8000. Principal Investigator
05
Co-investigator & Bioinformatics lead
06
30/07/2018- 20/12/2019: Development of an in vitro intestinal dysbiosis model, USA Centers
for Disease Control and Prevention (CDC); Awarded value (100%): £327,740
Co-investigator & Bioinformatics lead
07
21/01/2019- 20/01/2026: COLO-COHORT (Colorectal Cancer Cohort) Study, Guts UK
Charity (fka Core); Awarded value (100%): £1.25 million.
Co-investigator & Bioinformatics lead.
08
01/09/2020- 27/11/2020: SARS-CoV-2 microbiome / viral excretion, EnteroBiotix; Awarded
value (100%): £8,903.
Co-investigator & Bioinformatics lead
09
01/11/2020- 30/04/2021: BSAC COVID microbiome, British Society for Antimicrobial; Awarded
value (100%):
£82,510.
Co-investigator & Bioinformatics lead.
10
01/10/2018- 31/03/2020: Effect of trehalose on C. difficile infection, Hayashibara Co. Ltd
(Industry); Awarded value (100%): £57,260.
Co-investigator & Bioinformatics lead
11
Funding through company projects for microbiome data analysis work:–
- – 2017-18: Summit Plc; CoDIFy- £27,905
- – 2017-18: Astellas; EXTEND- £23,740
- – 2018-19: Astellas; PROFILE- £25,964
I am a co-investigator (bioinformatics lead) on multiple large awards
12
- Marie Curie Experienced Researcher Fellowship (Initial Training Networks (ITN)-FP7) during 2011 2012. £102,822
- FP7 Marie Curie Initial Training Network (ITN) FightingDrugFailure (Grant Agreement Number 238132).
- FightingDrugFailure ITN focusing the area of Pharmacogenomics.
13
International Science & Technology (ISAT) Linkages Fund (Germany): During my Ph.D. I helped Prof. Daniel Huson to obtain this grant, which supported me for collaborative research (including travel) with Massy University New Zealand during the period 2009.
